Verapamil inhibits influenza A virus replication

Area of Science:

• Virology
• Cell Biology
• Pharmacology

Background:

• Calcium channel blockers modulate calcium ion (Ca++) flux across cell membranes.
• Intracellular calcium-dependent activities are crucial for various cellular processes, including viral replication.
• Calmodulin is a key calcium-binding protein involved in regulating cellular functions.

Purpose of the Study:

• To investigate the effect of Verapamil, a calcium channel blocker, on influenza virus replication.
• To explore the role of calmodulin in influenza virus replication.
• To determine if calcium channel blockers can serve as tools for studying influenza virus replication.

Main Methods:

• Influenza virus replication was studied in Madin-Darby canine kidney cells and murine pulmonary macrophages.
• Verapamil was added at different stages of the viral replication cycle.
• Chlorpromazine, a calmodulin-binding drug, was also tested for its effect on viral replication.

Main Results:

• Verapamil demonstrated an inhibitory effect on influenza virus replication.
• The antiviral effect of Verapamil was observed even when added late in the replication cycle.
• Chlorpromazine also inhibited influenza virus replication in the tested cell systems.

Conclusions:

• Verapamil and chlorpromazine likely inhibit influenza virus replication by disrupting calmodulin-dependent processes essential for late viral synthesis or assembly.
• Calcium channel blockers represent a novel approach for investigating the mechanisms of influenza virus replication.